Fert, Ingrid http://orcid.org/0000-0003-1389-1159
Douguet, Laëtitia
Vesin, Benjamin
Moncoq, Fanny
Noirat, Amandine
Authié, Pierre
Ciret, Sylvain
Le Chevalier, Fabien
Blanc, Catherine
Vitrenko, Yakov
Charneau, Pierre
Majlessi, Laleh
Anna, François http://orcid.org/0000-0002-9170-6556
Funding for this research was provided by:
Institut Pasteur
Article History
Received: 30 November 2023
Accepted: 23 May 2024
First Online: 10 June 2024
Competing interests
: P.C. is the founder and CSO of TheraVectys. I.F., L.D., B.V., F.M., A.N., P.A., F.L.C. and F.A. are employees of TheraVectys. L.M. has a consultancy activity for TheraVectys. I.F., L.D., F.M., A.N., P.C., L.M. and F.A. are inventors of a pending patent directed to the potential of Lenti-HPV-07 vaccination against HPV-induced cancers. Other authors declare no competing interests.